Screening for gynecologic conditions with pelvic examination US preventive services task force recommendation statement

JAMA - Journal of the American Medical Association

Volumn 317, Issue 9, 2017, Pages 947-953

  Bibbins Domingo, Kirsten ^a   Grossman, David C ^b   Curry, Susan J ^c   Barry, Michael J ^d   Davidson, Karina W ^e   Doubeni, Chyke A ^f   Epling, John Jr W ^g   García, Francisco A R ^h   Kemper, Alex R ⁱ   Krist, Alex H ^j,k   Kurth, Ann E ^l   Landefeld, C Seth ^m   Mangione, Carol M ⁿ   Phillips, William R ^o   Phipps, Maureen G ^p   Silverstein, Michael ^q   Simon, Melissa ^r   Siu, Albert L ^s,t   Tseng, Chien Wen ^u  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b GROUP HEALTH RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF IOWA   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e Och Spine at New York Presbyterian Hospitals   (United States)

^f UNIVERSITY OF PENNSYLVANIA   (United States)

^g SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

^h Pima County Health Department   (United States)

ⁱ DUKE UNIVERSITY   (United States)

^j Fairfax Family Practice Residency   (United States)

^k VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^l YALE UNIVERSITY   (United States)

^m UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

ⁿ UNIVERSITY OF CALIFORNIA   (United States)

^o UNIVERSITY OF WASHINGTON   (United States)

^p BROWN UNIVERSITY   (United States)

^q BOSTON UNIVERSITY   (United States)

^r NORTHWESTERN UNIVERSITY   (United States)

^s MOUNT SINAI HOSPITAL   (United States)

^t VETERANS AFFAIRS MEDICAL CENTER   (United States)

^u UNIVERSITY OF HAWAII   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ASYMPTOMATIC DISEASE; CHLAMYDIASIS; EARLY DIAGNOSIS; GONORRHEA; GYNECOLOGIC DISEASE; GYNECOLOGICAL EXAMINATION; HUMAN; MEASUREMENT ACCURACY; PELVIC EXAMINATION; PRACTICE GUIDELINE; PREVENTIVE HEALTH SERVICE; REVIEW; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; UNITED STATES; UTERINE CERVIX CANCER; ADOLESCENT; ADULT; ADVISORY COMMITTEE; AGED; EARLY CANCER DIAGNOSIS; FEMALE; GENITAL DISEASES, FEMALE; MASS SCREENING; MIDDLE AGED; YOUNG ADULT;

ADOLESCENT; ADULT; ADVISORY COMMITTEES; AGED; EARLY DETECTION OF CANCER; FEMALE; GENITAL DISEASES, FEMALE; GYNECOLOGICAL EXAMINATION; HUMANS; MASS SCREENING; MIDDLE AGED; YOUNG ADULT;

EID: 85015908413     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2017.0807     Document Type: Review

References (25)

1. National Center for Health Statistics, Centers for Disease Control and Prevention. National Ambulatory Medical Care Survey: 2012 state and national summary tables. https://www.cdc.gov/nchs/data/ahcd/namcs-summary/2012-namcs-web-tables.pdf. Accessed January 17, 2017.
2. Moyer VA; U.S. Preventive Services Task Force. Screening for cervical cancer: U.S. Preventive Services Task Force recommendation statement [published correction appears in Ann Intern Med. 2013;158(11):852]. Ann Intern Med. 2012;156(12):880-891, W312.
3. LeFevre ML; U.S. Preventive Services Task Force. Screening for Chlamydia and gonorrhea: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2014;161(12):902-910.
4. Guirguis-Blake JM, Henderson JT, Perdue LA, Whitlock EP. Screening for Gynecologic Conditions With Pelvic Examination: A Systematic Review for the US Preventive Services Task Force. Evidence Synthesis No. 147. Rockville, MD: Agency for Healthcare Research and Quality; 2017. AHRQ publication 15-05220-EF-1.
5. Guirguis-Blake JM, Henderson JT, Perdue LA. Periodic screening pelvic examination: Evidence report and systematic review for the US Preventive Services Task Force. JAMA. doi:10.1001/jama.2016 .12819
6. Tiemstra JD, Pela E. Urinary symptoms after a routine pelvic exam. J AmBoard Fam Med. 2011;24 (3):290-295.
7. Henderson JT, Harper CC, Gutin S, SaraiyaM, Chapman J, Sawaya GF. Routine bimanual pelvic examinations: Practices and beliefs of US obstetrician-gynecologists. Am J Obstet Gynecol. 2013;208(2):109.
8. Stormo AR, Cooper CP, Hawkins NA, SaraiyaM. Physician characteristics and beliefs associated with use of pelvic examinations in asymptomatic women. Prev Med. 2012;54(6):415-421.
9. Moyer VA; U.S. Preventive Services Task Force. Screening for ovarian cancer: U.S. Preventive Services Task Force reaffirmation recommendation statement. Ann Intern Med. 2012;157(12):900-904.
10. LeFevre ML; U.S. Preventive Services Task Force. Behavioral counseling interventions to prevent sexually transmitted infections: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2014;161(12):894-901.
11. Health Resources & Services Administration. Women's preventive services guidelines. https://www.hrsa.gov/womensguidelines2016/index.html.Accessed January 17, 2017.
12. National Cancer Institute. Cancer stat facts: Ovarian cancer. https://seer.cancer.gov/statfacts/html/ovary.html. Accessed January 17, 2017.
13. Buys SS, Partridge E, Greene MH, et al; PLCO Project Team. Ovarian cancer screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial: Findings from the initial screen of a randomized trial. Am J Obstet Gynecol. 2005;193(5):1630-1639.
14. Doroudi M, Kramer BS, Pinsky PF. The bimanual ovarian palpation examination in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial: Performance and complications [published online on November 30, 2016]. J Med Screen. doi:10.1177/0969141316680381
15. Jacobs I, Stabile I, Bridges J, et al. Multimodal approach to screening for ovarian cancer. Lancet. 1988;1(8580):268-271.
16. Adonakis GL, Paraskevaidis E, Tsiga S, Seferiadis K, Lolis DE. A combined approach for the early detection of ovarian cancer in asymptomatic women. Eur J Obstet Gynecol Reprod Biol. 1996;65 (2):221-225.
17. Grover S, Quinn MA,Weideman P, et al. Screening for ovarian cancer using serum CA125 and vaginal examination: Report on 2550 females. Int J Gynecol Cancer. 1995;5(4):291-295.
18. Gutman RE, Peipert JF,Weitzen S, Blume J. Evaluation of clinical methods for diagnosing bacterial vaginosis. Obstet Gynecol. 2005;105(3): 551-556.
19. Eschenbach DA, Hillier S, Critchlow C, Stevens C, DeRouen T, Holmes KK. Diagnosis and clinical manifestations of bacterial vaginosis. Am J Obstet Gynecol. 1988;158(4):819-828.
20. Koutsky LA, Stevens CE, Holmes KK, et al. Underdiagnosis of genital herpes by current clinical and viral-isolation procedures. N Engl J Med. 1992; 326(23):1533-1539.
21. Wølner-Hanssen P, Krieger JN, Stevens CE, et al. Clinical manifestations of vaginal trichomoniasis. JAMA. 1989;261(4):571-576.
22. Qaseem A, Humphrey LL, Harris R, Starkey M, Denberg TD; Clinical Guidelines Committee of the American College of Physicians. Screening pelvic examination in adult women: A clinical practice guideline from the American College of Physicians. Ann Intern Med. 2014;161(1):67-72.
23. American Academy of Family Physicians. Clinical practice guideline: Screening pelvic examination in adult women. http://www.aafp .org/patient-care/browse/type.tag-clinical-preventive-services-recommendations.html. Accessed January 17, 2017.
24. Committee on Gynecologic Practice. Committee opinion No. 534: well-woman visit. Obstet Gynecol. 2012;120(2, pt 1):421-424.
25. Conry JA, Brown H. Well-Woman Task Force: Components of thewell-woman visit. Obstet Gynecol. 2015;126(4):697-701.